Glucocorticoids and Selumetinib Are Highly Synergistic in RAS Pathway Mutated Childhood Acute Lymphoblastic Leukemia Through Upregulation of BIM.

Haematologica - Italy
doi 10.3324/haematol.2017.185975
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

RAS Oncogene Mutations and Outcome of Therapy for Childhood Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Childhood Acute Lymphoblastic Leukemia

Oncologist
Cancer ResearchMedicineOncology
1997English

Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: BIM Finally

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Genetic Variants in the Folate Pathway and Risk of Childhood Acute Lymphoblastic Leukemia

Cancer Causes and Control
Cancer ResearchOncology
2011English

Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2019English

Nutritional Considerations in Childhood Acute Lymphoblastic Leukemia

Cancer and Oncology Research
2020English

Genomic Characterization of Childhood Acute Lymphoblastic Leukemia

Seminars in Hematology
Hematology
2013English

Cross-Resistance to Five Glucocorticoids in Childhood Acute Lymphoblastic and Non-Lymphoblastic Leukemia Samples Tested by the MTT Assay: Preliminary Report.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2002English

Editorial: Prognostic Factors in Childhood Acute Lymphoblastic Leukemia

Pediatric Hematology and Oncology
Child HealthOncologyPediatricsPerinatologyHematology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy